Table: Aska Pharmaceutical Holdings - 9-MTH group results

ASKA Pharmaceutical Holdings

03/02/2025 06:32

Feb 3 (Reuters)- 
             Aska Pharmaceutical Holdings Co., Ltd. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Dec 31, 2024        Dec 31, 2023     Mar 31, 2025 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             49.93               48.82            63.00    
                 (+2.3 pct)          (+3.3 pct)       (+0.2 pct)  
  Operating          5.50                5.53             6.70    
                 (-0.6 pct)          (+9.6 pct)       (+3.1 pct)  
  Recurring          5.45                5.63             6.70    
                 (-3.3 pct)          (+7.3 pct)       (+2.7 pct)  
  Net                4.10                6.46             5.00    
                 (-36.5 pct)         (+54.4 pct)      (-33.7 pct) 
  EPS            144.59 yen          228.13 yen       176.50 yen  
  Ann Div                             40.00 yen        50.00 yen  
  -Q2 div         25.00 yen           20.00 yen                   
  -Q4 div                             20.00 yen        25.00 yen  
  
  NOTE - Aska Pharmaceutical Holdings Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4886.T